1. 2022-RA-660-ESGO Characterization of extended treatment benefit from three phase 1 and 3 clinical trials examining patients with folate receptor alpha-positive recurrent ovarian cancer treated with single-agent mirvetuximab soravtansine. (20th October 2022) Authors: Oaknin, Ana; Lorusso, Domenica; Oza, Amit; Colombo, Nicoletta; van Gorp, Toon; O'Malley, David; Banerjee, Susana; Murphy, Conleth; Harter, Philipp; Konecny, Gottfried; Kaminsky, Marie-Christine; Method, Michael; Wang, Jiuzhou; Coleman, Robert L; Birrer, Michael; Matulonis, Ursula; Moore, Kathleen Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 62 A comparison of percutaneous and surgical revascularisation strategies following an equipoise decision in a heart team meeting. (4th June 2021) Authors: Mailey, Jonathan; Ahmed, Mahmoud; Shahmohammadi, Michael; Murphy, Conleth Journal: Heart Issue: Volume 107(2021)Supplement 1 Page Start: A52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Issue 1 (January 2018) Authors: Colleoni, Marco; Luo, Weixiu; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Hitre, Erika; Graas, Marie-Pascale; Simoncini, Edda; Kamby, Claus; Thompson, Alastair; Loibl, Sibylle; Gavilá, Joaquín; Kuroi, Katsumasa; Marth, Christian; Müller, Bettina; O'Reilly, Seam... Journal: Lancet oncology Issue: Volume 19:Issue 1(2018) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. O028/#376 Clinical benefit of mirvetuximab soravtansine in ovarian cancer patients with high folate receptor alpha expression: results from the soraya study. (4th December 2022) Authors: Coleman, Robert L; Matulonis, Ursula; Lorusso, Domenica; Oaknin, Ana; Pignata, Sandro; Denys, Hannelore; Colombo, Nicoletta; Gorp, Toon Van; Konner, Jason; Marin, Margarita Romeo; Harter, Philipp; Murphy, Conleth; Wang, Jiuzhou; Noble, Elizabeth; Esteves, Brooke; Method, Michael Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase II trial of patupilone in patients with brain metastases from breast cancer. (26th January 2014) Authors: Peereboom, David M.; Murphy, Conleth; Ahluwalia, Manmeet S.; Conlin, Alison; Eichler, April; Van Poznak, Catherine; Baar, Joseph; Elson, Paul; Seidman, Andrew D. Journal: Neuro-oncology Issue: Volume 16(2014)Supplement 4 Page Start: 579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. TP019/#1556 PICCOLO: an open-label, single arm, phase 2 study of mirvetuximab soravtansine in recurrent platinum sensitive, high-grade epithelial ovarian cancers with high folate-alpha expression. (4th December 2022) Authors: Secord, Angeles Alvarez; Lewin, Sharon; Method, Michael; Murphy, Conleth Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗